期刊
JOURNAL OF CELL SCIENCE
卷 122, 期 1, 页码 126-135出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.035279
关键词
Matrix metalloproteinase; Smooth muscle cell; Dedifferentiation; LDL receptor-related protein; PDGFR beta
类别
资金
- Academy of Finland
- Finnish Cancer Foundation
- Sigrid Juselius Foundation
- Biocentrum Helsinki
- Novo Nordisk Foundation
- Helsinki University Hospital Fund
- University of Helsinki
At sites of vessel-wall injury, vascular smooth muscle cells (VSMCs) can dedifferentiate to express an invasive and proliferative phenotype, which contributes to the development of neointimal lesions and vascular disorders. Herein, we demonstrate that the loss of the VSMC differentiated phenotype, as the repression of contractile-protein expression, is correlated with a dramatic upregulation of the membrane-anchored matrix metalloproteinase MT1-MMP (also known as MMP14 and membrane-type 1 matrix metalloproteinase). Matrix metalloproteinase (MMP) inhibitors or MT1-MMP deficiency led to attenuated VSMC dedifferentiation, whereas the phenotypic switch was re-engaged following the restoration of MT1-MMP activity in MT1-MMP-/- cells. MT1-MMPdependent dedifferentiation was mediated by the PDGFBB -PDGFR beta pathway in parallel with the proteolytic processing of the multifunctional LDL receptor-related protein LRP1 and the dynamic internalization of a PDGFR beta-beta 3-integrin -MT1-MMP-LRP1 multi-component complex. Importantly, LRP1 silencing allowed the PDGF-BB-induced dedifferentiation program to proceed in the absence of MT1-MMP activity, supporting the role of unprocessed LRP1 as a gatekeeper of VSMC differentiation. Hence, MT1-MMP and LRP1 serve as a new effector-target-molecule axis that controls the PDGF-BB-PDGFR beta-dependent VSMC phenotype and function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据